Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc Discussion of ADA Data Regarding its t:slim X2 with Control-IQ Technology System Transcript

Jun 10, 2019 / 12:00AM GMT
Release Date Price: €62.59
Operator

Good day, ladies and gentlemen, and welcome to the Discussion of the ADA Data Conference Call. (Operator Instructions) As a reminder, this call is being recorded.

I will now turn the conference over to your host, Ms. Susan Morrison, EVP and Chief Administrative Officer. Ma'am, you may begin.

Susan M. Morrison
Tandem Diabetes Care, Inc. - Executive VP & Chief Administrative Officer

Thank you. Hello, everyone, and thanks for joining us. Today's discussion will include forward-looking statements. These statements reflect management's expectations about future events, product development time lines and financial performance and operating plans and speak only as of today's date. There are risks and uncertainties that could cause actual results to differ materially from those anticipated or projected in our forward-looking statements.

A list of factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is highlighted in our press release issued earlier today and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot